Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation TrialU. Gatzemeier, Joachim von Pawel, Jaromı́r Roubec et al.|Journal of Clinical Oncology|2007Cited by 879
Results of a phase III trial of erlotinib (OSI-774) combined with cisplatin and gemcitabine (GC) chemotherapy in advanced non-small cell lung cancer (NSCLC)U. Gatzemeier, Joachim von Pawel, A Płużańska et al.|Journal of Clinical Oncology|2004Cited by 300